Comments
Loading...
Vaccinex (VCNX) Forecast
NewsEarningsVaccinex (VCNX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVaccinex (NASDAQ:VCNX) Stock Quotes, Forecast and News Summary
Vaccinex Stock (NASDAQ: VCNX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vaccinex (VCNX) stock?
You can purchase shares of Vaccinex (NASDAQ:VCNX) through any online brokerage.
Who are Vaccinex (VCNX) competitors?
Other companies in Vaccinex’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and T2 Biosystems (NASDAQ:TTOO).
What is the forecast, or price target, for Vaccinex (VCNX) stock?
There is no analysis for Vaccinex to provide a consensus price target.
What is the current price for Vaccinex (VCNX)?
The stock price for Vaccinex (NASDAQ: VCNX) is $3.72 last updated November 20, 2024 at 7:24 PM EST.
Does Vaccinex (VCNX) pay a dividend?
There are no upcoming dividends for Vaccinex.
When is Vaccinex (NASDAQ:VCNX) reporting earnings?
Vaccinex’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Vaccinex (VCNX) going to split?
There is no upcoming split for Vaccinex.
What sector and industry does Vaccinex (VCNX) operate in?
Vaccinex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.